The mechanistic complexities of phycotoxins: Toxicology of Azaspiracids and Yessotoxins

Advances in Molecular Toxicology

Volumn 8, Issue , 2014, Pages 1-33

  Botana, Luis M ^a   Alfonso, Amparo ^a   Vale, Carmen ^a   Vilariño, Natalia ^a   Rubiolo, Juan ^a   Alonso, Eva ^a   Cagide, Eva ^b  

^a Department of Agricultural and Forestry Engineering   (Spain)

^b CIFGA Laboratorio   (Spain)

Author keywords

Azaspiracids; Kinase; Phosphodiesterase; Phycotoxin; Signal transduction; Toxicology; Yessotoxins

Indexed keywords

AZASPIRACID; CALCIUM; CALCIUM ION; CYCLIC AMP; PHOSPHOTRANSFERASE; POTASSIUM CHANNEL HERG; STRESS ACTIVATED PROTEIN KINASE; YESSOTOXIN;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; AUTOPHAGY; CYTOSKELETON; CYTOSOL; CYTOTOXICITY; GENE EXPRESSION; HUMAN; IMMUNOREGULATION; INTOXICATION; MITOCHONDRION; NONHUMAN; SIGNAL TRANSDUCTION; TOXICOLOGY;

EID: 84907501856     PISSN: 18720854     EISSN: 22122044     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63406-1.00001-5     Document Type: Chapter

References (149)

1. Vlamis A., Katikou P. Ecobiology and geographical distribution of potentially toxic marine dinoflagellates. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2014, 569-625. CRC Press, Boca Raton. third ed. L.M. Botana (Ed.).
2. Torgersen T., Aasen J., Aune T. Diarrhetic shellfish poisoning by okadaic acid esters from Brown crabs (Cancer pagurus) in Norway. Toxicon 2005, 46(5):572-578.
3. Botana A.M., et al. Current situation on analysis of marine toxins. Rev. Anal. Chem. 2012, 32(1):15-34.
4. Holmes M.J., Brust A., Lewis R.J. Dinoflagellate toxins: an overview. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2014, 3-38. CRC Press, Boca Ratón. L.M. Botana (Ed.).
5. Lopez-Rosales L., et al. Simultaneous effect of temperature and irradiance on growth and okadaic acid production from the marine dinoflagellate Prorocentrum belizeanum. Toxins (Basel) 2014, 6(1):229-253.
6. Holmes M.J., et al. Strain dependent production of ciguatoxin precursors (gambiertoxins) by Gambierdiscus toxicus (Dinophyceae) in culture. Toxicon 1991, 29(6):761-775.
7. Otero P., et al. Effects of environmental regimens on the toxin profile of Alexandrium ostenfeldii. Environ. Toxicol. Chem. 2010, 29(2):301-310.
8. Laabir M., et al. Influence of environmental factors on the paralytic shellfish toxin content and profile of Alexandrium catenella (Dinophyceae) isolated from the Mediterranean Sea. Mar. Drugs 2013, 11(5):1583-1601.
9. Murata M., Yasumoto T. The structure elucidation and biological activities of high molecular weight algal toxins: maitotoxin, prymnesins and zooxanthellatoxins. Nat. Prod. Rep. 2000, 17(3):293-314.
10. Ciminiello P., et al. Putative palytoxin and its new analogue, ovatoxin-a, in Ostreopsis ovata collected along the Ligurian coasts during the 2006 toxic outbreak. J. Am. Soc. Mass Spectrom. 2008, 19(1):111-120.
11. Nicolaou K.C., Frederick M.O., Aversa R.J. The continuing saga of the marine polyether biotoxins. Angew. Chem. 2008, 47(38):7182-7225.
12. Botana L.M., et al. Measurement of algal toxins in the environment. Environment: Water and Waste 2011, Volume S1:268-291. John Willey & Sons Ltd., Chichester. R.A. Meyers (Ed.).
13. Catterall W.A., Morrow C.S. Binding to saxitoxin to electrically excitable neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 1978, 75(1):218-222.
14. Payandeh J., et al. The crystal structure of a voltage-gated sodium channel. Nature 2011, 475(7356):353-358.
15. Wingerd J.S., Vetter I., Lewis R.J. Voltage-gated sodium channels as therapeutic targets. Therapeutic Targets. Modulation, Inhibition and Activation 2012, 63-122. John Wiley & Sons, Hoboken, NJ. L.M. Botana, M.I. Loza (Eds.).
16. Bialojan C., Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 1988, 256(1):283-290.
17. Allingham J.S., Miles C.O., Rayment I. A structural basis for regulation of actin polymerization by pectenotoxins. J. Mol. Biol. 2007, 371(4):959-970.
18. Alfonso A., et al. Surface plasmon resonance biosensor method for palytoxin detection based on na+, k+-ATPase affinity. Toxins (Basel) 2014, 6(1):96-107.
19. de la Rosa L.A., et al. Maitotoxin-induced calcium entry in human lymphocytes: modulation by yessotoxin, Ca(2+) channel blockers and kinases. Cell Signal. 2001, 13(10):711-716.
20. Bourne Y., et al. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(13):6076-6081.
21. Rodriguez L.P., et al. Development of a solid-phase receptor-based assay for the detection of cyclic imines using a microsphere-flow cytometry system. Anal. Chem. 2013, 85(4):2340-2347.
22. Ramsdell J.S. Domoic acid, the molecular and integrative basis to domoic acid toxicity. Phytotoxins, Chemistry and Biochemistry 2007, 223-250. Blackwell Publishing, Ames, Iowa. L.M. Botana (Ed.).
23. MCMahon T., Silke J. Winter toxicity of unknown aetiology in mussels. Harmful Algae 1996, 14:2.
24. Satake M., et al. Azaspiracid, a new marine toxin having unique spiro ring assemblies, isolated from Irish mussels Mytilus edulis. J. Am. Chem. Soc. 1998, 120(38):9967-9968.
25. Nicolaou K., et al. Total synthesis and structural elucidation of azaspiracid-1. Synthesis-based analysis of originally proposed structures and indication of their non-identity to the natural product. J. Am. Chem. Soc. 2006, 128(7):2258-2267.
26. Nicolaou K.C., et al. Total synthesis of the proposed azaspiracid-1 structure, part 2: coupling of the C1-C20, C21-C27, and C28-C40 fragments and completion of the synthesis. Angew. Chem. Int. Ed. Engl. 2003, 42(31):3649-3653.
27. Frederick M.O., et al. Structural assignment and total synthesis of azaspiracid-1. Phytotoxins, Chemistry and Biochemistry 2007, 297-309. Blackwell Publishing, Ames, Iowa. L.M. Botana (Ed.).
28. James K.J., et al. Detection of five new hydroxyl analogues of azaspiracids in shellfish using multiple tandem mass spectrometry. Toxicon 2003, 41(3):277-283.
29. Hess P., et al. Azaspiracids: chemistry, biosynthesis, metabolism, and detection. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2014, 799-821. CRC Press, Boca Ratón. L.M. Botana (Ed.).
30. James K.J., et al. Ubiquitous 'benign' alga emerges as the cause of shellfish contamination responsible for the human toxic syndrome, azaspiracid poisoning. Toxicon 2003, 41(2):145-151.
31. Tillmann U., et al. Azadinium spinosum gen. et sp. nov. (Dinophyceae) identified as a primary producer of azaspiracid toxins. Eur. J. Phycol. 2009, 44:63-79.
32. Krock B., et al. New azaspiracids in Amphidomataceae (Dinophyceae). Toxicon 2012, 60(5):830-839.
33. Magdalena A.B., et al. The first identification of azaspiracids in shellfish from France and Spain. Toxicon 2003, 42:105-108.
34. Torgersen T., et al. Structural confirmation and occurrence of azaspiracids in Scandinavian brown crabs (Cancer pagurus). Toxicon 2008, 51(1):93-101.
35. Vale P., Bire R., Hess P. Confirmation by LC-MS/MS of azaspiracids in shellfish from the Portuguese north-western coast. Toxicon 2008, 51(8):1449-1456.
36. Alvarez G., et al. First identification of azaspiracid and spirolides in Mesodesma donacium and Mulinia edulis from Northern Chile. Toxicon 2010, 55(2-3):638-641.
37. Potvin E., et al. First report of the photosynthetic dinoflagellate genus Azadinium in the Pacific Ocean: morphology and molecular characterization of Azadinium cf. poporum. J. Eukaryot. Microbiol. 2012, 59(2):145-156.
38. Tillmann U., et al. AZA: the producing organisms-biology and trophic transfer. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2014, 773-795. CRC Press, Boca Ratón. L.M. Botana (Ed.).
39. Alfonso C., et al. Evaluation of various pH and temperature conditions on the stability of azaspiracids and their importance in preparative isolation and toxicological studies. Anal. Chem. 2008, 80(24):9672-9680.
40. Panel E.C. Opinion of the scientific panel on contaminants in the food chain on a request from the European Commission on marine biotoxins in shellfish-azaspiracids. EFSA J. 2008, 723:1-52.
41. Twiner M.J., Hess P., Doucette G.J. Azaspiracids: toxicology, pharmacology and risk assessment. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2014, 824-855. CRC Press, Boca Ratón. L.M. Botana (Ed.).
42. McCarron P., et al. Formation of Azaspiracids-3, -4, -6, and -9 via decarboxylation of carboxyazaspiracid metabolites from shellfish. J. Agric. Food Chem. 2009, 57(1):160-169.
43. Aasen J.A., et al. Sub-lethal dosing of azaspiracid-1 in female NMRI mice. Toxicon 2010, 56(8):1419-1425.
44. Aasen J.A., et al. Combined oral toxicity of azaspiracid-1 and yessotoxin in female NMRI mice. Toxicon 2011, 57(6):909-917.
45. Klontz K.C., et al. Mussel-associated azaspiracid intoxication in the United States. Ann. Intern. Med. 2009, 150(5):361.
46. Ito E., et al. Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon 2000, 38:917-930.
47. Ito E., et al. Chronic effects in mice caused by oral administration of sublethal doses of azaspiracid, a new marine toxin isolated from mussels. Toxicon 2002, 40(2):193-203.
48. Aune T. Oral toxicity of mixtures of lipophilic marine algal toxins in mice 2009, Quae Publishing, Versailles, France. P. Lassus (Ed.).
49. Aune T., et al. Study of possible combined toxic effects of azaspiracid-1 and okadaic acid in mice via the oral route. Toxicon 2012, 60(5):895-906.
50. Roman Y., et al. Azaspiracid-1, a potent, nonapoptotic new phycotoxin with several cell targets. Cell Signal. 2002, 14(8):703-716.
51. Twiner M.J., et al. Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian cell lines. Toxicon 2005, 45(7):891-900.
52. Vilarino N., et al. Irreversible cytoskeletal disarrangement is independent of caspase activation during in vitro azaspiracid toxicity in human neuroblastoma cells. Biochem. Pharmacol. 2007, 74(2):327-335.
53. Cao Z., et al. Involvement of caspase activation in azaspiracid-induced neurotoxicity in neocortical neurons. Toxicol. Sci. 2010, 114(2):323-334.
54. Twiner M.J., et al. Induction of apoptosis pathways in several cell lines following exposure to the marine algal toxin azaspiracid. Chem. Res. Toxicol. 2012, 25(7):1493-1501.
55. Vale C., et al. The c-Jun-N-terminal kinase is involved in the neurotoxic effect of azaspiracid-1. Cell Physiol. Biochem. 2007, 20(6):957-966.
56. Vale C., et al. Cytotoxic effect of azaspiracid-2 and azaspiracid-2-methyl ester in cultured neurons: involvement of the c-Jun N-terminal kinase. J. Neurosci. Res. 2008, 86(13):2952-2962.
57. Carragher N.O., et al. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J. Biol. Chem. 2001, 276(6):4270-4275.
58. Vilarino N., et al. Azaspiracid substituent at C1 is relevant to in vitro toxicity. Chem. Res. Toxicol. 2008, 21(9):1823-1831.
59. Alfonso A., et al. Azaspiracids modulate intracellular pH levels in human lymphocytes. Biochem. Biophys. Res. Commun. 2006, 346(3):1091-1099.
60. Alfonso A., et al. Azaspiracid-4 inhibits Ca2+ entry by stored operated channels in human T lymphocytes. Biochem. Pharmacol. 2005, 69(11):1627-1636.
61. Roman Y., et al. Effects of Azaspiracids 2 and 3 on intracellular cAMP, [Ca2+], and pH. Chem. Res. Toxicol. 2004, 17(10):1338-1349.
62. Schlumberger S., et al. The marine polyether gambierol enhances muscle contraction and blocks a transient K(+) current in skeletal muscle cells. Toxicon 2010, 56(5):785-791.
63. Schlumberger S., et al. Dual action of a dinoflagellate-derived precursor of Pacific ciguatoxins (P-CTX-4B) on voltage-dependent K(+) and Na(+) channels of single myelinated axons. Toxicon 2010, 56:768-775.
64. Mattei C., et al. Neurotoxins targeting receptor site 5 of voltage-dependent sodium channels increase the nodal volume of myelinated axons. J. Neurosci. Res. 1999, 55(6):666-673.
65. Gaudry-Talarmain Y.M., et al. Reversed mode Na(+)-Ca2+ exchange activated by ciguatoxin (CTX-1b) enhances acetylcholine release from Torpedo cholinergic synaptosomes. Ann. N.Y. Acad. Sci. 1996, 779:404-406.
66. Molgo J., et al. Ciguatoxin-induced changes in acetylcholine release and in cytosolic calcium levels. Bull. Soc. Pathol. Exot. 1992, 85(5 Pt 2):486-488.
67. Vale C., et al. Effects of azaspiracid-1, a potent cytotoxic agent, on primary neuronal cultures. A structure-activity relationship study. J. Med. Chem. 2007, 50(2):356-363.
68. Alonso E., et al. Calcium oscillations induced by gambierol in cerebellar granule cells. J. Cell. Biochem. 2010, 110(2):497-508.
69. Vilarino N. Marine toxins and the cytoskeleton: azaspiracids. FEBS J. 2008, 275(24):6075-6081.
70. Vilarino N., et al. Cell growth inhibition and actin cytoskeleton disorganization induced by azaspiracid-1 structure-activity studies. Chem. Res. Toxicol. 2006, 19(11):1459-1466.
71. Ronzitti G., et al. Azaspiracid-1 alters the E-cadherin pool in epithelial cells. Toxicol. Sci. 2007, 95(2):427-435.
72. Twiner M., et al. Transcriptional profiling and inhibition of cholesterol biosynthesis in human T lymphocyte cells by the marine toxin azaspiracid. Genomics 2008, 91:289-300.
73. Vale C., et al. Cell volume decrease as a link between azaspiracid-induced cytotoxicity and c-Jun-N-terminal kinase activation in cultured neurons. Toxicol. Sci. 2010, 113(1):158-168.
74. Kellmann R., et al. Proteomic response of human neuroblastoma cells to azaspiracid-1. J. Proteomics 2009, 72(4):695-707.
75. Bellocci M., et al. Azaspiracid-1 inhibits endocytosis of plasma membrane proteins in epithelial cells. Toxicol. Sci. 2010, 117(1):109-121.
76. Sala G.L., et al. Azaspiracid-1 inhibits the maturation of cathepsin D in mammalian cells. Chem. Res. Toxicol. 2013, 26(3):444-455.
77. Twiner M.J., et al. Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels. Chem. Res. Toxicol. 2012, 25(9):1975-1984.
78. Ferreiro S.F., et al. In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats. Arch. Toxicol. 2014, 88(2):425-434.
79. Satake M., MacKenzie L., Yasumoto T. Identification of Protoceratium reticulatum as the biogenetic organ of yessotoxin. Nat. Toxins 1997, 5(4):164-167.
80. Miles C.O., et al. Polyhydroxylated amide analogs of yessotoxin from Protoceratium reticulatum. Toxicon 2005, 45(1):61-71.
81. Murata M., et al. Isolation and structure of Yessotoxin, a novel polyether compound implicated in diarrhetic shellfish poisoning. Tetrahedron Lett. 1987, 28:5869-5872.
82. Satake M., et al. Two new analogs of yessotoxin, homoyessotoxin and 45-hydroxyhomoyessotoxin, isolated from mussels of the Adriatic Sea. Nat. Toxins 1997, 5(3):107-110.
83. Ciminiello P., et al. Yessotoxin in mussels of the northern Adriatic Sea. Toxicon 1997, 35(2):177-183.
84. Lee J., et al. Diarrhetic shellfish toxins in Nowegian mussels. Nippon Suisan Gakkaishi 1988, 54:1953-1957.
85. Ciminiello P., et al. Isolation of adriatoxin, a new analogue of yessotoxin from mussels of the Adriatic sea. Tetrahedron Lett. 1998, 39(48):8897-8900.
86. Draisci R., et al. High levels of yessotoxin in mussels and presence of yessotoxin and homoyessotoxin in dinoflagellates of the Adriatic Sea. Toxicon 1999, 37(8):1187-1193.
87. Pistocchi R., et al. Toxin levels and profiles in microalgae from the north-Western Adriatic Sea-15 years of studies on cultured species. Mar. Drugs 2012, 10(1):140-162.
88. Finch S.C., et al. Isolation and identification of (44-R, S)-44,55-dihydroxyyessotoxin from Protoceratium reticulatum, and its occurrence in extracts of shellfish from New Zealand, Norway and Canada. Toxicon 2005, 46(2):160-170.
89. Miles C.O., et al. Isolation of 41a-homoyessotoxin and the identification of 9-methyl-41a-homoyessotoxin and nor-ring A-yessotoxin from Protoceratium reticulatum. Chem. Res. Toxicol. 2004, 17(11):1414-1422.
90. Miles C.O., et al. Isolation of a 1,3-enone isomer of heptanor-41-oxoyessotoxin from Protoceratium reticulatum cultures. Toxicon 2004, 44(3):325-336.
91. Munday R., Aune T., Rossini G.P. Toxicology of the Yessotoxins. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2008, 329-339. CRC Press (Taylor and Francis Group), Boca Raton, FL. L.M. Botana (Ed.).
92. Panel E.C. Scientific opinion on marine biotoxins in shellfish-Yessotoxin group. EFSA Panel on Contaminants in the Food Chain (CONTAM). EFSA J. 2008, 907:1-62.
93. Aune T., et al. Comparison of oral and intraperitoneal toxicity of yessotoxin towards mice. Toxicon 2002, 40(1):77-82.
94. Tubaro A., et al. Short-term oral toxicity of homoyessotoxins, yessotoxin and okadaic acid in mice. Toxicon 2004, 43(4):439-445.
95. Tubaro A., et al. Oral and intraperitoneal acute toxicity studies of yessotoxin and homoyessotoxins in mice. Toxicon 2003, 41(7):783-792.
96. Hess P., Aasen J. Chemistry, origins and distribution of yessotoxin and its analogues. Phytotoxins, Chemistry and Biochemistry 2007, 187-202. Blackwell Publishing, Ames, Iowa. L.M. Botana (Ed.).
97. COMMISSION REGULATION (EU) No 786/2013 of 16 August 2013 amending Annex III to Regulation (EC) No 853/2004 of the European Parliament and of the Council as regards the permitted limits of yessotoxins in live bivalve molluscs. Official Journal of the European Communities 2013, L220:14. Commission regulation.
98. Ogino H., Kumagai M., Yasumoto T. Toxicologic evaluation of yessotoxin. Nat. Toxins 1997, 5:255-259.
99. Aune T., et al. Effect of mouse strain and gender on LD(50) of yessotoxin. Toxicon 2008, 52(4):535-540.
100. Terao K., et al. Histopathological studies on experimental marine toxin poisoning-5. The effects in mice of yessotoxin isolated from Patinopecten yessoensis and of a desulfated derivative. Toxicon 1990, 28:1095-1104.
101. Tubaro A., et al. Yessotoxins: a toxicological overview. Toxicon 2010, 56(2):163-172.
102. Munday R. Toxicology of seafood toxins: a critical review. Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection 2014, 197-290. CRC Press, Boca Ratón. L.M. Botana (Ed.).
103. Tubaro A., et al. Ultrastructural damage to heart tissue from repeated oral exposure to yessotoxin resolves in 3 months. Toxicon 2008, 51(7):1225-1235.
104. Sosa S., et al. Repeated oral co-exposure to yessotoxin and okadaic acid: a short term toxicity study in mice. Toxicon 2013, 76:94-102.
105. Aune T. Toxicity of marine and freshwater algal biotoxins towards freshly prepared hepatocytes 1988.
106. Leira F., et al. Characterization of distinct apoptotic changes induced by okadaic acid and yessotoxin in the BE(2)-M17 neuroblastoma cell line. Toxicol. In Vitro 2002, 16(1):23-31.
107. Malaguti C., et al. Caspase activation and death induced by yessotoxin in HeLa cells. Toxicol. In Vitro 2002, 16(4):357-363.
108. Perez-Gomez A., et al. Potent neurotoxic action of the shellfish biotoxin yessotoxin on cultured cerebellar neurons. Toxicol. Sci. 2006, 90(1):168-177.
109. Korsnes M.S., et al. Induction of apoptosis by YTX in myoblast cell lines via mitochondrial signalling transduction pathway. Toxicol. In Vitro 2006, 20(8):1419-1426.
110. Korsnes M.S., et al. Apoptotic events induced by yessotoxin in myoblast cell lines from rat and mouse. Toxicol. In Vitro 2006, 20(7):1077-1087.
111. Korsnes M.S., et al. Cleavage of tensin during cytoskeleton disruption in YTX-induced apoptosis. Toxicol. In Vitro 2007, 21(1):9-15.
112. Malagoli D., Marchesini E., Ottaviani E. Lysosomes as the target of yessotoxin in invertebrate and vertebrate cell lines. Toxicol. Lett. 2006, 167(1):75-83.
113. Callegari F., Rossini G.P. Yessotoxin inhibits the complete degradation of E-cadherin. Toxicology 2008, 244(2-3):133-144.
114. Ronzitti G., Rossini G.P. Yessotoxin induces the accumulation of altered E-cadherin dimers that are not part of adhesive structures in intact cells. Toxicology 2008, 244(2-3):145-156.
115. Young C., et al. The algal metabolite yessotoxin affects heterogeneous nuclear ribonucleoproteins in HepG2 cells. Proteomics 2009, 9:2529-2542.
116. Pang M., et al. Characterization of apoptotic changes induced by yessotoxin in the Bel7402 human hepatoma cell line. Mol. Med. Rep. 2011, 4(3):547-552.
117. Pang M., et al. Yessotoxin induces apoptosis in HL7702 human liver cells. Mol. Med. Rep. 2012, 5(1):211-216.
118. Ares I.R., et al. Actin cytoskeleton of rabbit intestinal cells is a target for potent marine phycotoxins. J. Exp. Biol. 2005, 208(Pt 22):4345-4354.
119. L.M. Botana et al., Therapeutic use of yessotoxins as growth inhibitors of human tumoral cells, in Patent, U.o.S.d. Compostela, Editor 2004.
120. J.A. Rubiolo, L.M. Botana, H. López, Use of yessotoxin and its derivatives for the treatment of gliomas, in Patent, U.o.S.d. Compostela, Editor 2012, Spain.
121. Korsnes M.S. Yessotoxin as a tool to study induction of multiple cell death pathways. Toxins (Basel) 2012, 4(7):568-579.
122. Korsnes M.S., et al. Paraptosis-like cell death induced by yessotoxin. Toxicol. In Vitro 2011, 25:1764-1770.
123. Sperandio S., de Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(26):14376-14381.
124. de la Rosa L.A., et al. Modulation of cytosolic calcium levels of human lymphocytes by yessotoxin, a novel marine phycotoxin. Biochem. Pharmacol. 2001, 61(7):827-833.
125. Tobio A., et al. Role of yessotoxin in calcium and cAMP-crosstalks in primary and K-562 human lymphocytes: the effect is mediated by Anchor kinase a mitochondrial proteins. J. Cell. Biochem. 2012, 113(12):3752-3761.
126. Alfonso A., et al. Yessotoxin, a novel phycotoxin, activates phosphodiesterase activity. Effect of yessotoxin on cAMP levels in human lymphocytes. Biochem. Pharmacol. 2003, 65(2):193-208.
127. Alfonso A., et al. Recent advances in marine phycotoxin mechanisms of action. Toxines et Signalisation-Toxins and Signalling 2009, Editions de la SFET-SFET Editions, Paris.
128. Pazos M.J., et al. Study of the interaction between different phosphodiesterases and yessotoxin using a resonant mirror biosensor. Chem. Res. Toxicol. 2006, 19(6):794-800.
129. Pazos M.J., et al. Kinetic analysis of the interaction between yessotoxin and analogues and immobilized phosphodiesterases using a resonant mirror optical biosensor. Chem. Res. Toxicol. 2005, 18(7):1155-1160.
130. Dell'Ovo V., et al. In vitro effects of yessotoxin on a primary culture of rat cardiomyocytes. Toxicol. Sci. 2008, 106(2):392-399.
131. Alfonso A., et al. Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal. 2000, 12(5):343-350.
132. Omori K., Kotera J. Overview of PDEs and their regulation. Circ. Res. 2007, 100(3):309-327.
133. Fernández-Araujo A., et al. Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes. Int. J. Biochem. Cell. Biol. 2014, 53:89-101.
134. Landsverk H.B., et al. Regulation of anchoring of the RIIalpha regulatory subunit of PKA to AKAP95 by threonine phosphorylation of RIIalpha: implications for chromosome dynamics at mitosis. J. Cell Sci. 2001, 114(Pt 18):3255-3264.
135. Steen R.L., Collas P. Mistargeting of B-type lamins at the end of mitosis: implications on cell survival and regulation of lamins A/C expression. J. Cell Biol. 2001, 153(3):621-626.
136. Alonso E., et al. Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and beta-amyloid pathology. ACS Chem. Neurosci. 2013, 4(7):1062-1070.
137. Tobio A., et al. Protein kinase C modulates Aurora-kinase inhibition induced by CCT129202 in HMC-1(560), (816) cell lines. Antiinflamm. Antiallergy Agents Med. Chem. 2013, 12(3):265-276.
138. Rubiolo J.A., et al. Yessotoxin induces ER-stress followed by autophagic cell death in glioma cells mediated by mTOR and BNIP3. Cell Signal. 2014, 26(2):419-432.
139. Chang C.P., et al. Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology 2007, 45(2):286-296.
140. Li Y., et al. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J. Biol. Chem. 2007, 282(49):35803-35813.
141. Harding H.P., et al. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 2000, 5(5):897-904.
142. Harding H.P., et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 2000, 6(5):1099-1108.
143. Martin-Lopez A., et al. Cytotoxicity of yessotoxin and okadaic acid in mouse T lymphocyte cell line EL-4. Toxicon 2012, 60(6):1049-1056.
144. Lopez A.M., et al. Immunoregulatory potential of marine algal toxins yessotoxin and okadaic acid in mouse T lymphocyte cell line EL-4. Toxicol. Lett. 2011, 207(2):167-172.
145. Cole G., et al. Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 1988, 452(1-2):165-174.
146. Huang Y.Y., Kandel E.R. Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. Learn. Mem. 1994, 1(1):74-82.
147. Frey U., Huang Y.Y., Kandel E.R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993, 260(5114):1661-1664.
148. Vale C., et al. Profile for amyloid-beta and tau expression in primary cortical cultures from 3xTg-AD mice. Cell Mol. Neurobiol. 2010, 30(4):577-590.
149. L.M. Botana, E. Alonso, C. Vale, Use of yessotoxin and analogs and derivatives thereof for treating and/or preventing neurodegenerative diseases linked to tau and beta amyloid. Patent, 2011. PCT/ES2011/070078(ES P201030162 8): p. WO 2011/095668 A1.